A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX)
Completed · Not applicable · NCT05018650
Conditions: Acute Ischemic Stroke
At a glance
- Research payments reported, 2025
- $271,422
- U.S. investigators named
- 17
- Sites paid
- 17
- Planned or actual enrollment
- 250
About the trial
- Sponsor
- Route 92 Medical, Inc.
- Tested
- Route 92 Medical Reperfusion System (device)
- Dates
- Started 2021-12-21; completion 2024-05-22
- Results posted
- Not yet
The SUMMIT MAX study is a prospective, randomized, controlled, interventional clinical trial to evaluate the safety and effectiveness of the Route 92 Medical MonoPoint® Reperfusion System with the Hi Point 88 and HiPoint 70 Reperfusion Catheters for aspiration thrombectomy in acute ischemic stroke patients.
From ClinicalTrials.gov, last updated 2025-04-09. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Route 92 Medical, Inc. reported $271,422 in research payments for this study in 2025 (20 payments).
Products named: 088 Access System, Hipoint 088, Nipoint 088
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Lucian Maidan, M.D. Neurology · Sacramento, CA
- Ricardo A. Hanel, MD, PHD Neurosurgery · Jacksonville, FL
- Coleman O. Martin, MD Neuroradiology · Iowa City, IA
- Santiago Ortega Gutierrez, MD Interventional Radiology · Iowa City, IA
- Michael G. Abraham, MD Neurology · Kansas City, KS
- Nicolas Villelli, M.D. Neurosurgery · Lexington, KY
- Thanh Nguyen, MD Neurology · Burlington, MA
- Ajit S. Puri, M.D. Neuroradiology · Worcester, MA
- Priyank Khandelwal, M.D. Neurology · Newark, NJ
- Johanna T. Fifi, M.D. Neurosurgery · New York, NY
- Ronald J. Budzik, M.D. Radiology · Columbus, OH
- Esteban Cheng-ching, MD Neurology · Dayton, OH
- Clemens M. Schirmer, MD Neurosurgery · Danville, PA
- Mahesh Jayaraman, MD Interventional Radiology · Providence, RI
- Roberta Novakovic, MD Interventional Radiology · Dallas, TX
- Ramesh Grandhi, M.D. Neurosurgery · Salt Lake City, UT
- Ansaar T. Rai, M.D. Neuroradiology · Morgantown, WV
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- University of Utah Hospital and Clinics, UT $54,193
- $38,994
- University of Kansas Hospital, KS $29,832
- Mercy San Juan Medical Center, CA $27,867
- Riverside Methodist Hospital, OH $21,463
- Ut of Texas Southwestern University Hospital - William P. Clements Jr., TX $16,060
- Rhode Island Hospital, RI $14,114
- Baptist Health Medical Center - Jacksonville, FL $13,640
- Baptist Health Lexington, KY $12,210
- Geisinger Medical Center, PA $10,650
- Mount Sinai Hospital, NY $8,840
- Boston Medical Center, MA $6,877
- St Lukes Hospital of Kansas City, MO $6,400
- Robert Wood Johnson University Hospital, NJ $3,835
- Umass Memorial Medical Center/university Campus, MA $2,678
- University of Iowa Hospital & Clinics, IA $2,210
- Miami Valley Hospital, OH $1,260
- West Virginia University Hospitals, Inc, WV $300
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.